Trends of First-Line Targeted Therapy in Korean Patients With Metastatic Clear Cell Renal Cell Carcinoma: Sunitinib Versus Pazopanib, a Multicenter Study

Research output: Contribution to journalArticlepeer-review

Original languageKorean
Journal대한비뇨기종양학술지
StatePublished - 2022

Cite this